Regina Elena Cancer Institute

🇮🇹Italy
Ownership
Private
Employees
-
Market Cap
-
Website

Prothrombotic Factors and Anaesthesia in Prostate Cancer

First Posted Date
2013-12-02
Last Posted Date
2014-11-06
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
200
Registration Number
NCT01998685
Locations
🇮🇹

Department of Anaesthesiology, Regina Elena, National Cancer Institute, Roma, Italy

Clinical Outcomes and Costs Analyses in Use of Goal Directed Therapy

First Posted Date
2013-11-27
Last Posted Date
2016-04-07
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
200
Registration Number
NCT01995786
Locations
🇮🇹

Regina Elena CI, Rome, Italy

Sevoflurane Protective Effect on Ischemia Reperfusion Injury in Microvascular Surgery

First Posted Date
2013-10-30
Last Posted Date
2016-04-07
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
128
Registration Number
NCT01972230
Locations
🇮🇹

Regina Elena Cancer Institute, Rome, RM, Italy

Sevoflurane Protective Effect on Ischemia-reperfusion Injury. Multicenter, Randomized Controlled Trial

First Posted Date
2013-07-23
Last Posted Date
2016-04-07
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
132
Registration Number
NCT01905501
Locations
🇮🇹

Regina Elena CI, Rome, Italy

Goal Directed Therapy (GDT) in Cytoreductive Surgery (CRS) and Hyperthermic Intra Peritoneal Chemotherapy (Hipec)

First Posted Date
2013-06-21
Last Posted Date
2017-04-26
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
80
Registration Number
NCT01882920
Locations
🇮🇹

Regina Elena CI, Rome, Italy

Determination of Predictive Genetic Markers of Toxicity After Hypofractionated Radiotherapy in Breast Cancer Patients Post-Conservative Surgery

Completed
Conditions
First Posted Date
2011-03-16
Last Posted Date
2011-03-16
Lead Sponsor
Regina Elena Cancer Institute
Registration Number
NCT01316328
Locations
🇮🇹

Regina Elena NCI, Rome, Italy

A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC)

Phase 2
Conditions
Interventions
First Posted Date
2009-06-25
Last Posted Date
2011-07-22
Lead Sponsor
Regina Elena Cancer Institute
Target Recruit Count
104
Registration Number
NCT00927511
Locations
🇮🇹

Regina Elena Cancer Institute, Rome, RM, Italy

© Copyright 2024. All Rights Reserved by MedPath